AMENDMENTS TO THIS ANNOUNCEMENT CAN BE FOUND IN RED.

Billing Code: 4163-18-P

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Implementation of Programs for the Prevention, Care and Treatment of HIV/AIDS in the Federal Republic of Nigeria under the President's Emergency Plan for AIDS Relief  (PEPFAR)

Announcement Type: New

Funding Opportunity Number: CDC-RFA-PS07-730 

Catalog of Federal Domestic Assistance Number: 93.067

Key Dates:

Application Deadline: October 4, 2007

 

I. Funding Opportunity Description

Authority: This program is authorized under Public Law 108-25 (United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003) [22 U.S.C. 7601].

 

Background:

President Bush's Emergency Plan for AIDS Relief has called for immediate, comprehensive and evidence-based action to turn the tide of global HIV/AIDS. The initiative aims to treat more than two million HIV-infected people with effective combination anti-retroviral therapy (ART) by 2008; care for ten million HIV-infected and affected persons, including those orphaned by HIV/AIDS, by 2008; and prevent seven million infections by 2010, with a focus on 15 priority countries, including 12 in sub-Saharan Africa.  The five-year Strategy for the Emergency Plan is available at the following Internet address:  http://www.state.gov/s/gac/plan/c11652.htm.

Over the same time period, as part of a collective national response, the Emergency Plan goals specific to Nigeria are to treat at least 350,000 HIV-infected individuals; to care for 1,750,000 HIV-affected individuals, including orphans.

 

Purpose:

Under the leadership of the U.S. Global AIDS Coordinator, as part of the President's Emergency Plan, the U.S. Department of Health and Human Services (HHS) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation's strategic plan.

 

HHS focuses on two or three major program areas in each country.  Goals and priorities include the following:

 

 

The overarching goal of this funding announcement is to strengthen the capacity and scale of comprehensive HIV interventions in the Federal Republic of Nigeria.  Specifically, the purpose of the program is to provide HIV prevention to persons at increased risk for HIV infection, as well as treatment, care, and support to HIV-infected individuals in Nigeria.

 

HHS/Nigeria, in conjunction with other U.S. Government agencies, is supporting the Government of of the Federal Republic of Nigeria in the expansion of HIV prevention, care and treatment throughout the country.  The purpose of this announcement is to engage new partners that are currently working in Nigeria, as well as indigenous organizations, to continue to expand such interventions.  This program announcement covers a wide range of activities.  Individual applicants may, but do not have to, respond to all outcomes described in this announcement.  Applicants should focus only on program areas in which they have existing expertise and experience.  HHS anticipates making approximately four awards through this announcement.

 

The recipients will work in collaboration with the HHS Global AIDS Program (GAP) office in Nigeria, and Federal and State Departments of Health in Nigeria, to achieve program outcomes.  All activities implemented under this program should follow national and state policies and guidelines for the delivery of HIV interventions.  The recipients will work in collaboration with State and national Departments of Health, the U.S. Government in-country Emergency Plan team, and the HHS/GAP office in Nigeria office to improve the breadth, scale, and quality of HIV interventions available throughout the country.  In addition to program implementation, recipients should develop methods to develop the capacity of their own and other organizations responsible for the delivery of HIV interventions in the country.  Capacity-building might focus on host Government health agencies, local non-governmental organizations (NGOs), points-of-service delivery, or health-care professionals who are working at facilities not receiving direct support.

 

Through this new initiative, HHS/ will work with program recipients and the Government of Nigeria to strengthen capacity and expand activities in the following areas: (1) primary HIV prevention; (2) HIV care, support, and treatment; and (3) capacity and infrastructure development, especially for disease-surveillance and training.  HHS anticipates it will make four awards under this announcement.  We anticipatet one award could focus on, but would not necessarily be limited to, prevention in most-at-risk populations.  Two awards could focus on, but would not necessarily be limited to, prevention and care activities that focus on one or more of the following: the provision of PMTCT; linkage to HIV care for individuals infected with tuberculosis (TB/HIV); expansion of confidential HIV counseling and testing (C&T), including routine, opt-out and household testing; and community-based care for HIV-infected or -affected persons, linked to comprehensive HIV care for these targeted populations.  A fourth award could focus on the delivery of comprehensive treatment and care, including PMTCT, HIV C&T, TB/HIV, laboratory support, and the provision of anti-retrovirals.

  

Measurable outcomes of the program during the first 12 months of the award will be in alignment with the following performance goal(s) for the Emergency Plan relative to allocations of program-area-specific funding:

The subset of funding for PMTCT for HIV in this announcement is $1,200,000.  HHS expects that within one year of receiving the funds the awardee(s) will achieve the following outcomes:

1)      Number of service outlets that are providing the minimum package of PMTCT interventions, according to national and international standards:

a)      Five service outlets that are providing the minimum package of PMTCT interventions.

2)      Number of pregnant women who received confidential HIV counseling and testing for PMTCT, and received their test results:

a)      16,000 pregnant women who undergo confidential testing for HIV, receive counseling and receive their results.

3)      Number of pregnant women provided with a complete course of anti-retroviral (ARV) prophylaxis in a PMTCT setting:

a)      800 HIV-positive pregnant women have received a complete course of ARV prophylaxis

4)      Number of health workers trained in local languages in the provision of PMTCT, according to national and international standards:

a)      20 health-care workers trained in local languages to provide the minimum package of PMTCT interventions, according to national and international standards..

The subset of announcement funding for prevention/abstinence and being faithful for HIV is $100,000.  HHS expects that, within one year of receiving the funds, the awardee will achieve the following outcomes:

1)      Number of individuals reached through local-language community outreach that promotes HIV/AIDS prevention through abstinence and/or being faithful:

a)      16,000 individuals reached with abstinence and/or be faithful messaging in local languages.

2)      Number of individuals reached through local-language community outreach that promotes HIV/AIDS prevention through abstinence (a subset of the total reached with AB)

a)      16,000 individuals reached with abstinence and/or be faithful messaging in local languages (8,000 individuals of the 16,000 will be reached with abstinence messaging)

3)      Number of individuals trained in local languages to promote HIV/AIDS prevention through abstinence and/or being faithful:

a)      40 individuals trained in local languages to promote HIV/AIDS prevention through abstinence and/or being faithful.

There are no funds in the first year of this announcement for prevention of HIV medical ransmission through blood safety.  HHS expects that, within one year of receiving the funds, in subsequent program years the awardee will acheive the following outcomes:

1)   Number of service outlets that are carrying out blood-safety activities:

a)      X outlets that are carrying out blood-safety activities

2)      Number of individuals trained in local languages in blood safety:

a)      X individuals trained in local languages in blood-safety practices and screening techniques.

3)      There are no funds in the first year of this announcement for prevention of HIV medical transmission through injection-safety activities.  HHS/CDC expects that, within one year of receiving the funds, in subsequent program years, the awardee will achieve the following outcomes:

4)      Number of individuals trained in local languages in injection safety:

a)      X individuals trained in local languages in safe injection practices.

The subset of announcement funds allocated to condoms and other prevention programs is $200,000 in the first year.  HHS/CDC expects that, within one year after receiving the funds, the awardee will achieve the following outcomes:

1)      Number of targeted outlets that are distributing and promoting the correct and consistent use of condoms to persons engaged in high-risk behaviors:[1]

a)      Three outlets are distributing and promoting the correct and consistent use of condoms to persons engaged in high-risk behaviors.

2)      Number of individuals reached through local-language community outreach that promotes HIV/AIDS prevention through other behavior change beyond abstinence and/or being faithful

a)      20,000 individuals reached.

3)      Number of individuals trained in local languages to promote HIV/AIDS prevention through other behavior change beyond abstinence and/or being faithful:

a)      20 individuals training in local languages to promote HIV prevention through behaviour changes beyond abstinence and/or being faithful.

The subset of announcement funds allocated for Basic Care and Support is $600,000 in the first year.  HHS/CDC expects that, within one year after receiving the funds, the awardee will achieve the following outcomes:

1)      Number of service outlets that provide HIV-related palliative care (excluding TB/HIV):

a)      Five outlets will provide HIV-related palliative care (excluding TB/HIV).

2)      Number of individuals provided with HIV-related palliative care (excluding TB/HIV):

a)      40 individuals will have received HIV-related palliative care (excluding TB/HIV).

3)      Number of individuals trained in local languages to provide HIV palliative care (excluding TB/HIV):

The subset of announcement funds allocated for addressing TB and HIV coinfection is $566,700 in the first year.  HHS/CDC expects that, within one year after receiving the funds, the awardee will achieve the following outcomes:

1)      Number of service outlets that are providing clinical prophylaxis and/or treatment for tuberculosis (TB) to HIV-infected individuals (diagnosed or presumed) in a palliative-care setting:

a)      10 service outlets will provide treatment for TB to HIV-positive patients.

2)      Number of clients who are receiving TB-HIV care:

a)      4000 individuals will receive TB-HIV care.

The subset of announcement funds allocated for addressing pediatric care and support, orphans and vulnerable children (OVC) is $500,000 in the first year.  HHS/CDC expects that, within one year after receiving the funds, the following outcomes will be achieved:

1)      Number of OVC served by OVC programs:

a)      2,500 OVC clients served.

2)      Number of providers/caretakers trained in local languages in caring for OVC:

a)      20 health-care providers or caretakers trained in local languages.

The subset of announcement funds allocated for providing confidential counseling and testing (excluding PMTCT) is $805,000 in the first year.  HHS/CDC expects that, within one year after receiving the funds, the awardee will achieve the following outcomes:

1)      Number of service outlets that are providing confidential counseling and testing, according to national and international standards:

a)      Seven outlets will provide confidential counseling and testing to clients.

2)      Number of individuals who received confidential counseling and testing for HIV and received their test results:

a)      45,000 clients tested for HIV using nationally approved rapid-testing algorithms.

3)      Number of individuals trained in local languages in confidential counseling and testing, according to national and international standards:

a)      35 individuals will be trained in local languages in confidential counseling and testing using rapid HIV test kits.

The subset of announcement funds allocated for addressing treatment for HIV/AIDS through anti-retroviral (ARV) drugs, ARV care and laboratory infrastructure is $3,300,000.  Funding and outcomes in subsequent years could vary.  HHS/CDC expects that, within one year after receiving the first year funds, the  awardee will achieve the following outcomes:

  • Two outlets will be providing anti-retroviral therapy (includes PMTCT-Plus sites);
  • Two laboratories will have the capacity to perform 1) HIV tests  and 2) CD4 tests and or lymphocyte tests;
  • 700 individuals will have newly initiated anti-retroviral therapy during the reporting period (includes PMTCT-plus sites);
  • 700 individuals have received anti-retroviral therapy by the end of the reporting period (includes PMTCT plus sites);
  • 700 individuals will be receiving anti-retroviral therapy at the end of the reporting period (includes PMTCT plus sites);
  • 50 health workers will have received training in local languages to deliver ART care, according to national and/or international standards (includes PMTCT plus sites); and
  • 10 health workers will have received training in local languages in the provision of laboratory-related activities

The subset of announcement funds allocated for addressing treatment for HIV/AIDS strategic-information activities is $200,000.  Funding and outcomes in subsequent years could vary.  HHS/CDC expects that, within one year after receiving the first year funds, thw awardee will achieve the following outcomes:
  • Two local organizations will have received technical assistance for strategic-information activities; and
  • 10 individuals will have received training in strategic information (includes monitoring and evaluation, surveillance, and/or health-management information systems).

 

This announcement is intended for non-research activities supported by HHS/CDC.  If an applicant proposes research activities, HHS will not review the application.  For the definition of “research,” please see the HHS/CDC Web site at the following Internet address:  http://www.cdc.gov/od/science/regs/hrpp/researchDefinition.htm

 

Activities:

The recipient of these funds is responsible for activities in multiple program areas designed to target populations without access to ART in Nigeria.  Either the awardee will implement activities directly or will implement them through its subgrantees and/or subcontractors; the awardee will retain overall financial and programmatic management under the oversight of HHS/CDC and the strategic direction of the Office of the Global AIDS Coordinator.  The awardee must show a measurable progressive reinforcement of the capacity of indigenous organizations and local communities to respond to the national HIV epidemic, as well as progress towards the sustainability of activities.

 

Applicants should describe activities in detail that reflect the policies and goals outlined in the Five-Year Strategy for the President’s Emergency Plan.

 

The grantee will produce an annual operational plan, which the U.S. Government Emergency Plan team on the ground in Nigeria will review as part of the annual Emergency Plan for AIDS Relief Country Operational Plan review-and-approval process, managed by the Office of the U.S. Global AIDS Coordinator.  The grantee may work on some of the activities listed below in the first year and in subsequent years, and then progressively add others from the list to achieve all of the Emergency Plan performance goals, as cited in the previous section.  HHS/CDC, under the guidance of the U.S. Global AIDS Coordinator, will approve funds for activities on an annual basis, based on documented performance toward achieving Emergency Plan goals, as part of the annual Emergency Plan for AIDS Relief Country Operational Plan review-and-approval process.

 

Awardee activities for this program are as follows:

 
  1. PMTCT:  The subset of announcement funding for PMTCT for HIV is $1,200,000 in the first program year.  HHS/CDC expects, that within one year of award, these funds will permit 16,000 women to receive confidential counseling and testing for HIV, and will have received their results, in accordance with international standards and national guidelines.  This screening will identify at least 800 pregnant women as HIV-positive, and they and their newborns will be offered a complete course of anti-retroviral therapy and appropriate referral into networks for care and treatment.  Support for HIV-positive woment should include counseling and support for maternal nutrition and safe infant-feeding practices.     
  2. Abstinence and Be Faithful:  The subset of announcement funds allocated to abstinence and be faithful programs is $100,000 in the first program year.  HHS/CDC expects that, within one year of award, these funds will reach 16,000 individuals through activities (including training) to promote abstinence, including the delay of sexual activity or secondary abstinence, fidelity (including partner reduction), and establishing thse behaviors as social and community norms.  Activities should also educate individuals on the availability of routine, confidential counseling and testing.     
  3. Medical Transmission/Blood Safety:  There is no announcement funding in year one for medical transmission/blood safety activities.  In subsequent program years, if funding is available, activities should support a nationally coordinated blood program, which includes policies based on international best practices; infrastructure, equipment and supplies; donor-recruitment activities; blood collection, distribution, testing and transfusion; training; and management to ensure a safe and adequate blood supply.     
  4. Medical Transmission/Injection Safety:  There is no announcement funding allocated in year one for medical transmission/injection-safety activities.  In subsequent program years, if funding is available, activities should support policies based on international best practices, training, waste-management systems, advocacy and other activities to promote (medical) injection safety, including establishing a distribution/supply chain, and the safe and appropriate disposal of injection equipment and other related equipment and supplies.  Activity emphasis should be in settings where routine clinical work is with known, HIV-positive patients or routine, confidential counseling and testing programs.     
  5. Condoms and Other Prevention:  The subset of announcement funds allocated to condoms and other prevention programs is $200,000 in the first program year.  HHS/CDC expects that, within one year of award, these funds will provide prevention activities to 20,000 individuals, including activities such as the following: the purchase and promotion of the correct and consistent use of condoms; diagnosis, treatment, and management of STIs; messages/ programs to reduce the use of injecting drug(s); the confidential counseling and testing of persons in STI clinics; the diagnosis and treatment of sexually transmitted diseases in other medical clinical settings; and messages/programs to reduce other risks of persons engaged in high-risk behaviors.[2]  The social marketing of condoms should always be done in tandem with abstinence and be faithful behaviour-change interventions.  Activities may include prevention for HIV-positive clients, in synergy with care and support programs.     
  6. Basic Care and Support:  The subset of announcement funds allocated for basic care and support is $600,000 in the first year.  HHS/CDC expects that, within one year of award, these funds will reach 8,000 adult or adolescent HIV-positive individuals through clinic-based and home-/community-based activities aimed at optimizing quality of life for HIV-infected clients and their families throughout the continuum of illness by means of the diagnosis and relief of symptoms; psychological and spiritual support; clinical monitoring, related laboratory services and the management of opportunistic infections (excluding TB) and other HIV/AIDS-related complications (including pharmaceuticals); and culturally appropriate end-of-life care.  Activities should include network referral to treatment for HIV/AIDS or TB (if appropriate) and for care possibly not offered by the awardee.     
  7. Tuberculosis/HIV:  The subset of announcement funds allocated for addressing tuberculosis and HIV coinfection is $566,700 in the first year.  HHS/CDC expects that, within one year of award, these funds will reach 4,000 individuals to provide care, including exams for tuberculosis, clinical monitoring, related laboratory services, the treatment and prevention of tuberculosis in HIV basic health care settings (including pharmaceuticals), screening and referral for HIV testing of active tuberculosis patients with unknown HIV status in settings such as Directly Observed Therapy, Short-course (DOTS) sites, and to clinical care.      
  8. Orphans and Vulnerable Children (OVC):  The subset of announcement funds allocated for addressing pediatric HIV care and support and OVC is $500,000 in the first year.  HHS/CDC estimates that, within one year of award, these funds will provide care or support to 2,500 individuals, either HIV-positive children or HIV-negative children rendered vulnerable from HIV.  Activities should primarily include palliative care for HIV-positive pediatric patients, including basic health care and support; TB/HIV prevention, management and treatment; as well as related laboratory services and pharmaceuticals.  Activities can also include improving the lives of orphans and other vulnerable children and families affected by HIV/AIDS.  The emphasis should be on strengthening communities to meet the needs of orphans and other vulnerable children affected by HIV/AIDS, supporting community-based responses, helping children and adolescents to meet their own needs, creating a supportive social and policy environment, etc.  Activities could include training caregivers in local languages, increasing access to education, economic support, institutional capacity-building, targeted food and nutrition support, legal aid, etc.      
  9. Counseling and Testing:  The subset of announcement funds allocated for providing routine, confidential counseling and testing (excluding PMTCT) is $805,000 in the first year.  HHS/CDC expects that, within one year of award, these funds will support activities for 45,000 individuals to receive routine, confidential HIV counseling and testing.  Emphasis should be on conducting confidential HIV counseling and testing in high-risk environments, such as sites that offer directly observed therapy for TB, mobile outreach to populations such as women in prostitution, STI clinics, and inpatient wards in clinical settings.  Activities must include participation in the national network of care, support, and treatment for HIV/AIDS and TB, where appropriate, which means referrals into all Government of Nigeria HIV/AIDS treatment sites, whether funded though the Emergency Plan, the Global Fund, or other sources.     
  10. Antiretroviral Treament:  The subset of announcement funds allocated for addressing treatment for HIV/AIDS through anti-retroviral (ARV) drugs and services is $2,100,000 in the first year.   HHS/CDC expects that, within one year, these funds will support 2,200 individuals who require ARV treatment for HIV.  Treatment costs covered can include infrastructure, training clinicians and other providers, exams, clinical monitoring, related laboratory services and community-adherence activities.  Clinical monitoring and management of opportunistic infections is classified under basic care and support (palliative care), TB-HIV, or OVC for pediatric palliative care.  Programs must address demand generation, participation in the national network of care and treatment, and address issues such as the appropriate useage of second-line drugs.     
  11. Laboratory Infrastructure:  The subset of announcement funds allocated for addressing lab infrastructure is $1,200,000 in the first program year.  Activities will include the development and strengthening of laboratory facilities to support HIV/AIDS-related activities including the purchase of equipment and commodities through transport and competitive processes, the provision of quality assurance, staff training and other technical assistance.  Specific laboratory services and consumables supporting testing for PMTCT, confidential counseling and testing, TB/HIV, strategic information, basic care or treatment should receive funding from within their specific program areas.     
  12. Strategic Information:  The subset of announcement funds allocated for addressing strategic information is $200,000 in the first year.  HHS/CDC expects these funds will aid in the development of improved tools and models for collecting, analyzing and disseminating HIV/AIDS behavioral and biological surveillance and monitoring information; facility surveys; other monitoring and health-management information systems; assisting countries to establish and/or strengthen such systems; targeted program evaluations (including operations research); developing and disseminating best practices to improve program efficiency and effectiveness; planning/evaluating national prevention, care and treatment efforts; and the analysis and quality assurance of demographic and health data related to HIV/AIDS.   Monitoring-and-evaluation activities must work as part of the Nigerian national HIV/AIDS framework, by participating in the agreed country-level monitoring-and-evaluation system that provides data to the Nigerian national AIDS coordinating authority, consistent with the “Three Ones” principles.      
  13. General to all Activities:  Activities that incorporate training should seek to produce and use materials in the local languages where possible.  Applicants under this announcement may apply to perform one or more activities but do not have to apply for all activities.  Applications should indicate linkages with other activies.  Examples would be confidential counseling and testing or PMTCT that refer HIV-positive patients to basic care and support.    

 

Administration

An awardee under this funding competition must comply with all HHS management requirements for meeting participation and progress and financial reporting for this cooperative agreement (See HHS Activities and Reporting sections below for details), and comply with all policy directives established by the Office of the U.S. Global AIDS Coordinator.

 

In a cooperative agreement, HHS staff is substantially involved in the program activities, above and beyond routine grant monitoring. 

HHS Activities for this program are as follows:

1.      Organize an orientation meeting with the grantee to brief it on applicable U.S. Government, HHS, and Emergency Plan expectations, regulations and key management requirements, as well as report formats and contents.  The orientation could include meetings with staff from HHS agencies and the Office of the U.S. Global AIDS Coordinator.

 

2.      Review and approve the process used by the grantee to select key personnel and/or post-award subcontractors and/or subgrantees to be involved in the activities performed under this agreement, as part of the Emergency Plan for AIDS Relief Country Operational Plan review and approval process, managed by the Office of the U.S. Global AIDS Coordinator.

 

3.      Review and approve the grantee’s annual work plan and detailed budget, as part of the Emergency Plan for AIDS Relief Annual Country Operational Plan review and approval process, managed by the Office of the U.S. Global AIDS Coordinator.

 

4.      Review and approve the grantee’s monitoring-and-evaluation plan, including for compliance with the strategic-information guidance established by the Office of the U.S. Global AIDS Coordinator. 

 

5.      Meet on a monthly basis with the grantee to assess monthly expenditures in relation to approved work plan and modify plans, as necessary.

 

6.      Meet on a quarterly basis with the grantee to assess quarterly technical and financial progress reports and modify plans as necessary.

 

7.      Meet on an annual basis with the grantee to review annual progress report for each U.S. Government Fiscal Year, and to review annual work plans and budgets for subsequent year, as part of the Emergency Plan for AIDS Relief review and approval process for Country Operational Plans, managed by the Office of the U.S. Global AIDS Coordinator.

 

8.      Provide technical assistance, as mutually agreed upon, and revise annually during validation of the first and subsequent annual work plans.  This could include expert technical assistance and targeted training activities in specialized areas, such as strategic information, project management, confidential counseling and testing, palliative care, treatment literacy, and adult-learning techniques.

 

9.       Provide in-country administrative support to help grantee meet U.S. Government financial and reporting requirements approved by the Office of Management and Budget (OMB) under 0920-0428 (Public Health Service Form 5161).  

 

10.  Conducting implementing site monitoring visits to assure compliance with national guidelines, inspect for safe work environments for local staff, assess local staff training programs, and provide quality assurance for clinical and laboratory operations to ensure patient safety.  

 

11.  Collaborate with the awardee on designing and implementing the activities listed above, including, but not limited to the provision of technical assistance to develop program activities, data management and analysis, quality assurance, the presentation and possibly publication of program results and findings, and the management and tracking of finances.    

 

12.  Provide consultation and scientific and technical assistance based on appropriate, HHS/CDC and Office of the U.S. Global AIDS Coordinator documents to promote the use of best practices known at the time.

 

13.  Assist the recipient in developing and implementing quality-assurance criteria and procedures.    

 

14.  Facilitate in-country planning and review meetings for technical assistance activities.    

 

Please note: Either HHS staff or staff from organizations that have successfully competed for funding under a separate HHS contract, cooperative agreement or grant will provide technical assistance and training.

 

II. Award Information

Type of Award: Cooperative Agreement

HHS involvement in this program appears in the Activities Section above.

Award Mechanism: U2G – Global HIV/AIDS Non-Research Cooperative Agreements

In cooperation with other countries, international organizations, and other partners to conduct HIV/AIDS prevention, care and treatment non-research activities in international countries most heavily affected by the HIV/AIDS epidemic.

Fiscal Year Funds: 2007

Approximate Current Fiscal Year Funding: $8,000,000

Approximate Total Project Period Funding: $40,000,000 (This amount is an estimate, and is subject to availability of funds.) 

Approximate Number of Awards:  Four.

Approximate Average Award: $2,000,000 (This amount is for the first 12-month budget period, and includes direct costs (and indirect costs in the case of domestic grantees.)

Floor of Individual Award Range: $300,000

Ceiling of Individual Award Range: $8,000,000 (This ceiling is for the first 12-month budget period.)

Anticipated Award Date: October 31, 2007

Budget Period Length: 12 Months

Project Period Length: Five Years

Throughout the project period, HHS’s commitment to continuation of awards will be conditioned on the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the Federal Government, through the Emergency Plan for AIDS Relief review and approval process for Country Operational Plans, managed by the Office of the U.S. Global AIDS Coordinator.

 

III. Eligibility Information

III.1. Eligible Applicants

Eligible applicants that can apply for this funding opportunity appear below:

  • Public, non-profit organizations;
  • Private, non-profit organizations;
  • For-profit organizations;
  • Small, minority, and women-owned businesses;
  • Universities;
  • Colleges;
  • Research institutions;
  • Hospitals;
  • Community-based organizations;
  • Faith-based organizations;
  • Federally recognized Indian tribal Governments;
  • Indian tribes;
  • Indian tribal organizations;
  • U.S. State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau); and
  • Political subdivisions of U.S. States (in consultation with States).

A Bona Fide Agent is an agency/organization identified by a State as eligible to submit an application under the State's eligibility in lieu of a State application.  If applying as a bona fide agent of a State or local Government, a letter from the State or local Government as documentation of the status is required.  Place this documentation behind the first page of the application form.

 

III.2. Cost-Sharing or Matching

Matching funds are not required for this program.  If applicants receive funding from other sources to underwrite the same or similar activities, or anticipate receiving such funding in the next 12 months, they must detail how the disparate streams of financing complement each other.

 

III.3. Other

If an applicant requests a funding amount greater than the ceiling of the award range, HHS/CDC will not review the application.  

 

Special Requirements:

If the application is incomplete or non-responsive to the special requirements listed in this section, it will not enter into the review process.  HHS/CDC will notify the applicant the application did not meet submission requirements.

  • HHS/CDC will consider late applications non-responsive.  See section “IV.3.  Submission Dates and Times” for more information on deadlines.
  • Note: Title 2 of the United States Code Section 1611 states that an organization described in Section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting a grant, loan, or an award.

 

IV. Application and Submission Information

IV.1. Address to Request Application Package

To apply for this funding opportunity use application form PHS 5161-1.

Dun and Bradstreet Data Universal Number System

Each applicant agency or organization must have a Dun and Bradstreet Data Universal Numbering System (DUNS) number to apply for a grant or cooperative agreement from the Federal Government.  The DUNS number is a nine-digit identification number, which uniquely identifies business entities.  Obtaining a DUNS number is easy, and there is no charge.  To obtain a DUNS number, please go to the following Internet address:  http://fedgov.dnb.com/webform/displayHomePage.do;jsessionid=D12B99D19654F9B26C193B1EFDE3430B.  From the home page, 1) click on "Begin DUNS Search/Request Process", 2) select country and submit your organization information.  A DUNS number should be created within one day.  Please direct any questions to govt@dnb.com. 

 

For more information, see the HHS/CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/grantmain.htm.

If the application form does not have a DUNS number field, please write the DUNS number at the top of the first page of the application, and/or include the DUNS number in the cover letter that accompanies the application.

 

Electronic Submission:

HHS/CDC strongly encourages the applicant to submit the application electronically by using the forms and instructions posted for this announcement on www.Grants.gov, the official Federal agency-wide E-grant Web site.  Only applicants who apply on-line may forego submitting paper-copies of all application forms.  

Registering an organization through www.Grants.gov is the first step in submitting applications online.  Registration information is located in the “Get Registered” screen of www.Grants.gov.  For foreign organizations, the next step would be to obtain a NATO Commercial and Governmental Entity (NCAGE) code http://www.cdc.gov/od/pgo/funding/grantmain.htm.  While application submission through www.Grants.gov is optional, applicants are strongly encouraged to use this online tool.

Key tips for Registration on Grants.gov:
  • Please visit www.Grants.gov at least 30 days prior to filing an application to become familiar with the registration and submission processes.
  • The one-time registration process will take three to five days to complete.
  • Only the person who registers the organization on grants.gov can submit the application.  This is important to remember if the person who originally registered an organization on grants.gov is no longer working for that particular organization.
  • HHS/CDC suggests submitting electronic applications prior to the closing date so if difficulties are encountered, a hard copy of the application can be submitted prior to the deadline.

If technical difficulties are encountered in Grants.gov, customer service may be obtained by e-mail at support@grants.gov, or by phone 1-800-518-4726 (1-800-518-GRANTS).  The Customer Support Center is open from 7:00 a.m. to 9:00 p.m. Eastern Standard Time, Monday through Friday. 

 

Paper Submission:

Application forms and instructions are available on the HHS/CDC Web site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/forms.shtm

 

If access to the Internet is not available, or if difficulty is encountered in accessing the forms on-line, contact the HHS/CDC Procurement and Grants Office Technical Information Management Section (PGO-TIM) staff at 770-488-2700, who can mail the application forms.

 

IV.2. Content and Form of Submission

Application:

A Project Abstract must be submitted with the application forms.  The abstract must be submitted in the following format:
  • Maximum of one page
  • Font size:  12 point unreduced, Times New Roman
  • Single spaced
  • Paper size:  8.5 by 11 inches
  • Page margin size:  One inch

The Project Abstract must contain a summary of the proposed activity suitable for dissemination to the public.  It should be a self-contained description of the project and should contain a statement of objectives and methods to be employed.  It should be informative to other persons working in the same or related fields and insofar as possible understandable to a technically literate lay reader.  This Abstract must not include any proprietary/confidential information.

 

Applicants must submit a project narrative with the application forms, in the following format:

  • Maximum number of pages: 25 (If your narrative exceeds the page limit, HHS/CDC will only review the first pages that are within the page limit.);
  • Font size: 12-point, unreduced;
  • Double-spaced;
  • Paper size: 8.5 by 11 inches (preferred), or generally accepted paper size;
  • Page-margin size: One-inch;
  • Number all narrative pages;
  • Print only on one side of each page; and
  • Held together only by rubber bands or metal clips, not bound in any other way.

 

The narrative should address activities the applicant will conduct over the entire project period, and must include the following items, in the order listed:
  • Project Context and Background (Understanding and Need):  Describe the background and justify the need for the proposed project.  Describe the current infrastructure system; targeted geographical area(s), if applicable; and identified gaps or shortcomings of the current health systems and AIDS-control projects in Nigeria.
  • Project Strategy - Description and Methodologies:  Present a detailed operational plan for initiating and conducting the project.  Clearly describe the applicant’s technical approach/methods for implementing the proposed project.  Describe the existence of or plans to establish partnerships necessary to implement the project.  Describe linkages, if appropriate, with programs funded by the U.S. Agency for International Development.
  • Project Goals and Objectives:  Describe the overall goals of the project, and specific objectives that are measurable and time-phased, consistent with the objectives and numerical targets of the President’s Emergency Plan and for this Cooperative Agreement program as provided in the “Purpose” Section at the beginning of this Announcement.
  • Project Outputs:  Be sure to address each of the program objectives listed in the “Purpose” Section of this Announcement.  Measures must be specific, objective and quantitative, so as to provide meaningful outcome evaluation.
  • Project Contribution to the Goals and Objectives of the President’s Emergency Plan for AIDS Relief:  Provide specific measures of effectiveness to demonstrate accomplishment of the objectives of this program. 
  • Work Plan and Description of Project Components and Activities:  Be sure to address each of the specific tasks listed in the “Activities” Section of this Announcement.  Clearly identify specific assigned responsibilities for all key professional personnel. 
  • Performance Measures:  Measures must be specific, objective and quantitative.
  • Timeline (e.g., GANNT Chart)
  • Management of Project Funds and Reporting.

 

Applicants may include additional information in appendices.  The appendices and budget information will not count toward the narrative page limit.  This additional information includes the following:
  • Project Budget and Justification:

With staffing breakdown and justification, provide a line-item budget and a narrative with justification for all requested costs. Be sure to include, if any, in-kind support or other contributions provided by the national Government and its donors as part of the total project, but for which funding is not being requested.

 

Budgets must be consistent with the purpose; objectives of the Emergency Plan and the program activities listed in this Announcement, and must include the following:

·        Line-item breakdown and justification for all personnel, i.e., name, position title, annual salary, percentage of time and effort, and amount requested.

For each contract, list the following: (1) name of proposed contractor; (2) breakdown and justification for estimated costs; (3) description and scope of activities the contractor will perform; (4) period of performance; (5) method of contractor selection (e.g., competitive solicitation); and (6) methods of accountability.  Applicants should, to the greatest extent possible, employ transparent and open competitive processes to choose contractors; 

 
  • Curricula vitae of current staff who will work on the activity;
  • Job descriptions of proposed key positions to be created for the activity;
  • Quality-Assurance, Monitoring-and-Evaluation, and Strategic-Information Forms;
  • Applicant’s Corporate Capability Statement;
  • Letters of Support; and
  • Evidence of Legal Organizational Structure.

 

Additional requirements that could require submission of additional documentation with the application appear in Section “VI.2.  Administrative and National Policy Requirements.”

 

IV.3. Submission Dates and Times

Application Deadline Date: October 4, 2007

 

Explanation of Deadlines: The HHS/CDC Procurement and Grants Office must receive applications by 5:00 p.m. Eastern Time on the deadline date.

Electronic Submission: 

HHS/CDC will consider applications completed on-line through Grants.gov as formally submitted when the applicant organization’s Authorizing Official electronically submits the application to www.grants.gov.  The application will be electronically time/date stamped, which will serve as receipt of submission.  Applicants will receive an e-mail notice of receipt when HHS/CDC receives the application.

 

HHS/CDC will consider electronic applications as having met the deadline if the applicant organization’s Authorizing Official has submitted the application electronically to Grants.gov on or before the deadline date and time.

 

Paper Submission:

If an applicant submits an application by the United States Postal Service or commercial delivery service, the applicant must ensure the carrier will be able to guarantee delivery by the closing date and time.  If HHS/CDC receives the submission after the closing date because of: (1) carrier error, when the carrier accepted the package with a guarantee for delivery by the closing date and time; or (2) significant weather delays or natural disasters, the applicant will have the opportunity to submit documentation of the carrier’s guarantee.  If the documentation verifies a carrier problem, HHS/CDC will consider the submission as having been received by the deadline. 

 

If an applicant submits a hard-copy application, HHS/CDC will not notify the applicant upon receipt of the submission.  If questions arise on the receipt of the application, the applicant should first contact the carrier.  If the applicant still has questions, it should contact the HHS/CDC staff at (770) 488-2700.  The applicant should wait two to three days after the submission deadline before calling.  This will allow time for HHS/CDC to process and log submissions.

 

This announcement is the definitive guide on application content, submission address, and deadline.  It supersedes information provided in the application instructions.  If the application submission does not meet the deadline above, it will not be eligible for review, and HHS/CDC will discard it.  HHS/CDC will notify the applicant the application did not meet the submission requirements.

 

IV.4. Intergovernmental Review of Applications

Executive Order 12372 does not apply to this program.

 

IV.5. Funding Restrictions

Restrictions, which applicants must take into account while writing the budget, are as follows:
  • Recipients may not use funds for research.

·        Needle Exchange - No funds appropriated under this Act shall be used to carry out any program of distributing sterile needles or syringes for the hypodermic injection of any illegal drug.

·        Recipients may spend funds for reasonable program purposes, including personnel, training, travel, supplies and services.  Recipients may purchase equipment and complete renovations if deemed necessary to accomplish program objectives, and if authorized by, and in accordance with, applicable federal law and HHS/CDC policy and the funding stream used for this activity.

·        Applicants shall state all requests for funds contained in the budget in U.S. dollars.  Once HHS/CDC makes an award, foreign grantees will not be compensated for currency-exchange fluctuations through the issuance of supplemental awards.

·        The costs generally allowable in grants to domestic organizations are allowable to foreign institutions and international organizations, with the following exception: With the exception of the American University, Beirut, and the World Health Organization, HHS/CDC will not pay indirect costs (either directly

or through sub-award) to organizations located outside the territorial limits of the United States or to international organizations, regardless of their location.

·        Recipients may contract with other organizations under this program; however, recipients must perform a substantial portion of the activities (including program management and operations, and delivery of prevention services for which funds are required) relating to the management of sub-grants to local organizations and improving their capacity, and must award any subcontracts through a competitive and transparent process.

·        Recipients must obtain an annual audit of these HHS/CDC funds (program-specific audit) by a U.S.-based audit firm with international branches and current licensure/authority in-country, and in accordance with International Accounting Standards or equivalent standard(s) approved in writing by HHS/CDC.

·        A fiscal Recipient Capability Assessment may be required, prior to or post award, to review the applicant’s business management and fiscal

capabilities regarding the handling of U.S. Federal funds.

·        Prostitution and Related Activities

The U.S. Government is opposed to prostitution and related activities, which are inherently harmful and dehumanizing, and contribute to the phenomenon of trafficking in persons. 

 

Any entity that receives, directly or indirectly, U.S. Government funds in connection with this document (“recipient”) cannot use such U.S. Government funds to promote or advocate the legalization or practice of prostitution or sex trafficking.  Nothing in the preceding sentence shall be construed to preclude the provision to individuals of palliative care, treatment, or post-exposure pharmaceutical prophylaxis, and necessary pharmaceuticals and commodities, including test kits, condoms, and, when proven effective, microbicides. 

 

A recipient that is otherwise eligible to receive funds in connection with this document to prevent, treat, or monitor HIV/AIDS shall not be required to endorse or utilize a multisectoral approach to combating HIV/AIDS, or to endorse, utilize, or participate in a prevention method or treatment program to which the recipient has a religious or moral objection.  Any information provided by recipients about the use of condoms as part of projects or activities that are funded in connection with this document shall be medically accurate and shall include the public health benefits and failure rates of such use.

 

In addition, any recipient must have a policy explicitly opposing prostitution and sex trafficking.  The preceding sentence shall not apply to any “exempt organizations” (defined as the Global Fund to Fight AIDS, Tuberculosis and Malaria, the World Health Organization and its six Regional Offices, the International AIDS Vaccine Initiative or any United Nations agency).

 

The following definition applies for purposes of this clause:

·        Sex trafficking means the recruitment, harboring, transportation, provision, or obtaining of a person for the purpose of a commercial sex act.  22 U.S.C. § 7102(9).

 

All recipients must insert provisions implementing the applicable parts of this section, “Prostitution and Related Activities,” in all subagreements under this award.  These provisions must be express terms and conditions of the subagreement, must acknowledge that compliance with this section, “Prostitution and Related Activities,” is a prerequisite to receipt and expenditure of U.S. Government funds in connection with this document, and must acknowledge that any violation of the provisions shall be grounds for unilateral termination of the agreement prior to the end of its term.  Recipients must agree that HHS may, at any reasonable time, inspect the documents and materials maintained or prepared by the recipient in the usual course of its operations that relate to the organization’s compliance with this section, “Prostitution and Related Activities.”

 

All prime recipients that receive U.S. Government funds (“prime recipients”) in connection with this document must certify compliance prior to actual receipt of such funds in a written statement that makes reference to this document (e.g., “[Prime recipient's name] certifies compliance with the section, ‘Prostitution and Related Activities.’”) addressed to the agency’s grants officer.  Such certifications by prime recipients are prerequisites to the payment of any U.S. Government funds in connection with this document. 

 

Recipients' compliance with this section, “Prostitution and Related Activities,” is an express term and condition of receiving U.S. Government funds in connection with this document, and any violation of it shall be grounds for unilateral termination by HHS of the agreement with HHS in connection with this document prior to the end of its term.  The recipient shall refund to HHS the entire amount furnished in connection with this document in the event HHS determines the recipient has not complied with this section, “Prostitution and Related Activities.”

 

Guidance for completing the budget appears on the HHS/CDC Web site, at the following Internet address:

http://www.cdc.gov/od/pgo/funding/budgetguide.htm

 

IV.6. Other Submission Requirements

Application Submission Address:

Electronic Submission:

HHS/CDC strongly encourages applicants to submit applications electronically at www.Grants.gov.  The application package is available at www.Grants.gov.  Applicants are able to complete it off-line, and then upload and submit the application via the Grants.gov Web site.  HHS/CDC will not accept e-mail submissions.  If the applicant has technical difficulties in Grants.gov, it can reach customer service by e-mail at support@grants.gov, or by phone at 1-800-518-4726 (1-800-518-GRANTS).  The Customer Support Center is open from 7:00 a.m. to 9:00 p.m., Eastern Time, Monday through Friday. 

 

HHS/CDC recommends applicants submit their applications to Grants.gov early enough to resolve any unanticipated difficulties prior to the deadline.  Applicants may also

submit a back-up paper submission of the application.  HHS/CDC must receive any such paper submission in accordance with the requirements for timely submission detailed in Section IV.3. of the grant announcement. The applicant must clearly mark the paper submission:  “BACK-UP FOR ELECTRONIC SUBMISSION.”  The paper submission must conform to all requirements for non-electronic submissions.  If HHS/CDC receives both electronic and back-up paper submissions by the deadline, the electronic version will be considered as the official submission.

 

The applicant must submit all applications attachments using a PDF file format when submitting via Grants.gov.  Directions for creating PDF files are available on the Grants.gov Web site.  Use of file formats other than PDF could make the file unreadable for our staff.

 

OR

 

Paper Submission:

 

Applicants should submit the original and two hard copies of the application by mail or express delivery service to:

            Technical Information Management - PS07-730

            Procurement and Grants Office

            Centers for Disease Control and Prevention

            U.S. Department of Health and Human Services

2920 Brandywine Road, MS E-14

            Atlanta, GA 30341

 

V. Application Review Information

V.1. Criteria

Applicants are required to provide specific measures of effectiveness that will demonstrate the accomplishment of the various identified objectives of the cooperative agreement.  Measures of effectiveness must relate to the performance goals stated in the “Purpose” Section of this announcement.  Measures must be objective and quantitative, and must measure the intended outcome.  Applicants must submit the measures of effectiveness with the application, and they will be an element of evaluation.

 

HHS/CDC will evaluate the application against the following criteria:

 

Ability to Carry Out the Proposal (20 points)

Does the applicant demonstrate the local experience in Nigeria and institutional capacity (both management and technical) to achieve the goals of the project with documented good-governance practices?  Does the applicant have the ability to coordinate and collaborate with existing Emergency Plan partners and other donors, including the Global Fund and other U.S. Government Departments and agencies involved in implementing the Emergency Plan, including the U.S. Agency for International Development?  Is there evidence of leadership support and evidence of current or past efforts to enhance HIV prevention?  Does the applicant have the capacity to reach rural and other underserved populations in Nigeria?  Does the organization have the ability to target audiences that frequently fall outside the reach of the traditional media, and in local languages?  To what extent does the applicant provide letters of support?

 

Technical and Programmatic Approach (20 points)

Does the application include an overall design strategy, including measurable time lines, clear monitoring-and-evaluation procedures, and specific activities for meeting the proposed objectives?  Does the applicant display knowledge of the strategy, principles and goals of the President's Emergency Plan for AIDS Relief, and are the proposed activities consistent with and pertinent to that strategy and those principles and goals?  Does the applicant describe activities that are evidence-based, realistic, achievable, measurable and culturally appropriate to achieve the goals of the Emergency Plan?  Does the application propose to build on and complement the current national response in Nigeria with evidence-based strategies designed to reach underserved populations and meet the goals of the Emergency Plan?  Does the application include reasonable estimates of outcome targets?  (For example, the numbers of sites to be supported, number of clients the program will reach.)  To what extent does the applicant propose to work with other organizations?  The reviewers will assess the feasibility of the applicant's plan to meet the target goals, whether the proposed use of funds is efficient, and the extent to which the specific methods described are sensitive to the local culture.

 

Capacity-Building (15 points)

Does the applicant have a proven track-record of building the capacity of indigenous organizations and individuals in local languages?  Does the applicant have relevant experience in using participatory methods and approaches, in project planning and implementation?  Does the applicant describe an adequate and measurable plan to progressively build the capacity of local organizations and of target beneficiaries to respond to the epidemic?  If not a local indigenous organization, does the applicant articulate a clear exit strategy, which will maximize the legacy of this project in the intervention communities?  Does the capacity-building plan clearly describe how it will contribute to a) improved quality and geographic coverage of service delivery to achieve the "2,7,10" targets of the Emergency Plan, and b) (if not a local indigenous organization) an evolving role of the prime beneficiary with transfer of critical technical and management competence to local organizations/sites in support of a decentralized response?

 

Monitoring and Evaluation (15 points)

Does the applicant demonstrate the local experience and capability to implement rigorous monitoring and evaluation of the project?  Does the applicant describe a system for reviewing and adjusting program activities based on monitoring information obtained by using innovative, participatory methods and standard approaches?  Does the plan include indicators developed for each program milestone, and incorporated into the financial and programmatic reports?  Are the indicators consistent with the Emergency Plan Indicator Guide?  Is the system able to generate financial and program reports to show disbursement of funds, and progress towards achieving the numerical objectives of the President's Emergency Plan?  Is the plan to measure outcomes of the intervention, and the manner in which they will be provided, adequate?  Is the monitoring-and-evaluation plan consistent with the principles of the “Three Ones?”  Applicants must define specific output and outcome indicators must be defined in the proposal, and must have realistic targets in line with the targets addressed in the Activities section of this announcement.

 

Understanding of the Problem (10 points)

Does the applicant demonstrate a clear and concise understanding of the current national HIV/AIDS response in Nigeria and the cultural and political context relevant to the programmatic areas targeted?  Does the applicant display an understanding of the Five-Year Strategy and goals of the President's Emergency Plan in Nigeria?  To what extent does the applicant justify the need for this program within the target community?

 

Personnel (10 points)

Does the organization employ staff fluent in local languages who will work on this project?  Are the staff roles clearly defined?  As described, will the staff be sufficient to meet the goals of the proposed project?  If not an indigenous organization, does the staff plan adequately involve local individuals and organizations?  Are staff involved in this project qualified to perform the tasks described?  Curricula vitae provided should include information that they are qualified in the following:  management of HIV/AIDS prevention activities, especially confidential, voluntary counseling and testing; and the development of capacity-building among and collaboration between Governmental and non-governmental partners.

 

Administration and Management (10 points)

Does the applicant provide a clear plan for the administration and management of the proposed activities, and to manage the resources of the program, prepare reports, monitor and evaluate activities, audit expenditures and produce collect and analyze performance data?  Is the management structure for the project sufficient to ensure speedy implementation of the project?  If appropriate, does the applicant have a proven track record in managing large laboratory budgets; running transparent and competitive procurement processes; supervising consultants and contractors; using subgrants or other systems of sharing resources with community-based organizations, faith-based organizations or smaller non-governmental organizations; and providing technical assistance in laboratory or pharmacy management?  The grantee must demonstrate an ability to submit quarterly reports in a timely manner to the HHS/CDC office.

 

Budget (Reviewed, but not scored)

Is the itemized budget for conducting the project, along with justification, reasonable and consistent with stated objectives and planned program activities?  Is the budget itemized, well-justified and consistent with the Five-Year Strategy (2003-2008) and goals of the President's Emergency Plan and Emergency Plan activities?  If applicable, are there reasonable costs per client reached for both year one and later years of the project?

 

V.2. Review and Selection Process

The HHS/CDC Procurement and Grants Office (PGO) staff will review applications for completeness, and the HHS Global AIDS Program will review them for responsiveness.  Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process.  Applicants will receive notification that their application did not meet submission requirements.

 

An objective review panel will evaluate complete and responsive applications according to the criteria listed in the “V.1. Criteria” section above.  All persons who serve on the panel will be external to the U.S. Government Country Program Office in Nigeria.  The panel may include both Federal and non-Federal participants. 

 

V.3. Anticipated Announcement and Award Dates

The anticipated award date is October 31, 2007

 

VI. Award Administration Information

VI.1. Award Notices

Successful applicants will receive a Notice of Award (NoA) from the HHS/CDC Procurement and Grants Office.  The NoA shall be the only binding, authorizing document between the recipient and HHS/CDC.  An authorized Grants Management

Officer will sign the NoA, and mail it to the recipient fiscal officer identified in the application.

 

Unsuccessful applicants will receive notification of the results of the application review by mail.

 

VI.2. Administrative and National Policy Requirements

Successful applicants must comply with the administrative requirements outlined in 45 CFR Part 74 and Part 92, as appropriate.  The following additional requirements apply to this project:              
  • AR - 4             HIV/AIDS Confidentiality Provisions;    
  • AR - 6             Patient Care;     
  • AR - 9             Paperwork Reduction Act Requirements;           
  • AR - 12           Lobbying Restrictions;   
  • AR - 14           Accounting System Requirements;                                   
  • AR - 23           Compliance with 45 C.F.R. Part 87;      
  • AR - 24           Health Insurance Portability and Accountability Act Requirements;  and
  • AR - 25           Release and Sharing of Data.     

Additional information on the requirements is available on the HHS/CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm.

 

CDC Assurances and Certifications can be found on the CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/foamain.htm.

 

For more information on the Code of Federal Regulations, see the National Archives and Records Administration, at the following Internet address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html

 

VI.3. Reporting Requirements

The applicant must provide HHS/CDC with an original, plus two hard copies, of the following reports:

1.      Interim progress report, due no less than 90 days before the end of the budget period.  The progress report will serve as the non-competing continuation application, and must contain the following elements:

a.       Activities and Objectives for the Current Budget Period;

b.      Financial Progress for the Current Budget Period;

c.       Proposed Activity and Objectives for the New Budget Period Program;

d.      Budget;

e.       Measures of Effectiveness, including progress against the numerical goals of the President's Emergency Plan for AIDS Relief for Nigeria; and

f.        Additional Requested Information;

2.      Annual progress report, due 90 days after the end of the budget period.  Reports should include progress against the numerical goals of the President's Emergency Plan for AIDS Relief for Nigeria;

3.      Financial status report, due no more than 90 days after the end of the budget period; and

4.      Final financial performance reports, due no more than 90 days after the end of the project period.

Recipients must mail the reports to the Grants Management Specialist listed in the "VII. Agency Contacts" section of this announcement.

 

 

VII. Agency Contacts

HHS/CDC encourages inquiries concerning this announcement.

For general questions, contact:

     Technical Information Management Section

     Procurement and Grants Office

     Centers for Disease Control and Prevention

     U.S. Department of Health and Human Services

     2920 Brandywine Road, MS E-14

     Atlanta, GA 30341

     Telephone: 770-488-2700

 

For program technical assistance, contact:

John Vertefeuille, Project Officer

     Centers for Disease Control and Prevention

     U.S. Department of Health and Human Services

Global AIDS Program - Nigeria

1600 Clifton Road, MS E-41

Atlanta, GA 30333

Telephone: 410-383-9007

E-mail: foa@ng.cdc.gov

 

For financial, grants management, or budget assistance, contact:

     Larry Ware, Grants Management Specialist

     Procurement and Grants Office

     Centers for Disease Control and Prevention

     U.S. Department of Health and Human Services

     2920 Brandywine Road, Mail stop: K-75

     Atlanta, GA 30341

     Telephone: 770-488-4791

     E-mail: fwu6@cdc.gov

 

VIII. Other Information

Other HHS/CDC funding opportunity announcements are available on the HHS/CDC Web site, Internet address: http://www.cdc.gov/od/pgo/funding/FOAs.htm, and on the web site of the HHS Office of Global Health Affairs, Internet address: www.globalhealth.gov.


 

[1]  Behaviors that increase risk for HIV transmission include engaging in casual sexual encounters, engaging in sex in exchange for money or favors, having sex with an HIV-positive partner or one whose status is unknown, using drugs or abusing alcohol in the context of sexual interactions, and using intravenous drugs.  Women, even if faithful themselves, can still be at risk of becoming infected by their spouse, regular male partner, or someone using force against them.  Other high-risk persons or groups include men who have sex with men and workers who are employed away from home.  Awardees may not implement condom social marketing without also implementing abstinence and faithfulness behavior-change interventions.

[2]   Behaviors that increase risk for HIV transmission include engaging in casual sexual encounters, engaging in sex in exchange for money or favors, having sex with an HIV-positive partner or one whose status is unknown, using drugs or abusing alcohol in the context of sexual interactions, and using intravenous drugs.  Women, even if faithful themselves, can still be at risk of becoming infected by their spouse, regular male partner, or someone using force against them.  Other high-risk persons or groups include men who have sex with men and workers who are employed away from home.  Awardees may not implement condom social marketing without also implementing abstinence and faithfulness behavior-change interventions.

 

CDC Home Page: http://www.cdc.gov

CDC Funding Web Page: http://www.cdc.gov/od/pgo/funding/FOAs.htm  

CDC Forms Web Page: http://www.cdc.gov/od/pgo/funding/grants/app_and_forms.shtm